GoodRx Holdings, Inc. (GDRX) vs Omnicell, Inc. (OMCL)
- GoodRx Holdings, Inc. GDRX 3.36 −4.27%
- Omnicell, Inc. OMCL 35.39 −1.56%
GoodRx Holdings, Inc. and Omnicell, Inc. are both Health Information Services companies. Omnicell, Inc. is the larger, with a market value of $1.6B against $1.2B — 1.4× the size. Omnicell, Inc. trades at the lower P/E: 41.6× against 62.7×. Omnicell, Inc. grew revenue faster over the last twelve months: 8.45% against −1.83%. Omnicell, Inc. has the higher net margin (3.13% vs 2.07%) and the lower return on invested capital (3.10% vs 5.59%). Across the 22 metrics below, Omnicell, Inc. leads on 12 and GoodRx Holdings, Inc. on 10.
Valuation
Profitability
| Metric | GDRX | OMCL | Health Information Services median |
|---|---|---|---|
| Gross margin | 90.83% | 44.77% | 62.87% |
| Operating margin | 9.54% | 4.65% | (9.45%) |
| Net margin | 2.07% | 3.13% | (15.48%) |
| Free cash flow margin | 16.77% | 10.17% | 0.00% |
| Return on equity | 2.52% | 3.06% | (6.91%) |
| Return on assets | 0.89% | 1.89% | (6.28%) |
| Return on invested capital | 5.59% | 3.10% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack